Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT03741673
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Malignant Neoplasm
- Metastatic Malignant Neoplasm in the Brain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Quality-of-Life Assessment — OTHERAncillary studies
- Questionnaire Administration — OTHERAncillary studies
- Stereotactic Radiosurgery — RADIATIONUndergo SRS
Study Details
This phase III trial studies stereotactic radiosurgery (SRS) before surgery to see how well it works compared with SRS after surgery in treating patients with cancer that has spread to the brain (brain metastases). SRS is the delivery of focused, high-dose radiation given in a single session to the tumors, with a minimal dose given to uninvolved areas of the brain.
Key Dates
- Start date
- Nov 8, 2018
- Status verified
- Sep 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 180 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Group I (pre-operative SRS)Patients undergo SRS within 30 days of randomization followed by surgery within 30 days. Patients may undergo additional SRS if disease returns after treatment.
- Active Comparator: Group II (post-operative SRS)Patients undergo surgery within 30 days of randomization followed by standard of care SRS within 30 days. Patients may undergo additional SRS if disease returns after treatment.
Primary Outcome Measure
Leptomeningeal disease (LMD)-free rate [ Time Frame: At 1 year ]
Central Contacts
- Debra Yeboa713-563-2300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Debra N. Yeboa 713-563-2300 Debra N. Yeboa (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- New Assessment System in Measuring Symptom Distress in Cancer PatientsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas